GlassScriptPhysician profile
Grant R Conner
NPI 1932639226
$2,453.37
in general payments reported to CMS, 2019-2025
20 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $12.19 · 2021: $364 · 2022: $201 · 2023: $506 · 2024: $518 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $789.90 | 2022-2025 | |
| Glaxosmithkline, LLC. | $255.71 | 2022-2025 | Nucala |
| Stryker Corporation | $224.20 | 2019-2024 | Clarifix Cryotherapy Device, Xpress Ent Dilation System |
| Depuy Synthes Sales INC. | $211.35 | 2020-2023 | Matrixmandible, Matrixmidface |
| Kls-Martin L.P. | $145.80 | 2023-2024 | |
| Acclarent, INC | $128.34 | 2019 | |
| Alcon Vision LLC | $124.07 | 2021 | |
| Smith+Nephew, INC. | $94.50 | 2025 | Stravix, Tula |
| Integra Lifesciences Corporation | $86.01 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $77.76 | 2022-2025 | Dupixent |
| Amgen INC. | $53.77 | 2025 | Tezspire |
| Zimmer Biomet Holdings, INC. | $51.17 | 2019 | |
| Inspire Medical Systems, INC. | $35.99 | 2023 | Inspire |
| Medtronic, INC. | $33.74 | 2023 | Propel |
| Hologic Sales and Service, LLC | $30.60 | 2023 | Coolseal Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $27.70 | 2023 | Harmonic |
| Novartis Pharmaceuticals Corporation | $23.19 | 2022 | |
| Lilly USA, LLC | $22.18 | 2023 | Retevmo |
| Vertex Pharmaceuticals Incorporated | $19.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.21 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.